After an advisory panel to the U.S. Food and Drug Administration voted yesterday to authorize the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, some parents have questions, so Stanford has held an information session.
The virtual forum, which will take place this Thursday, November 4, will aim to present updates on studies at Stanford University regarding pediatric vaccination and what to do to ensure a successful vaccination campaign.
The virtual space through the Zoom platform will be available from 3:30 p.m. to 5:00 p.m. to register and send previous questions, which will be answered by the experts.